Autoimmine testing Flashcards

1
Q

Def of Autoimmunity

A
  • The process where the host immune system ceases to recognize one or more of the body’s normal constituents as self, creates autoantibodies that starts to attack its own (Cells - Tissues - Organs) causing inflammation & damage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Examples of Autoimmunity

A
  • Systemic Lupus Erythematosus (SLE).
  • Rheumatoid Arthritis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of Autoimmunity

A

Mostly Unknown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Def of Autoantibodies

A
  • Proteins created by the immune system when it fails to distinguish between self-antigens & non-self-antigens (foreign antigens) e.g. bacterial or viral.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are Autoantibodies directed against?

A

These autoantibodies may be directed against a variety of substrates including:

  • Intra-cellular antigens.
  • Cell surface antigens.
  • Extracellular antigens.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SLE

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Immunological testing for SLE

A
  • Antinuclear antibodies (ANA)
  • SLE specific antibodies
  • Complement proteins
  • Anti-platelet antibodies & Anti-erythrocyte antibodies
  • Anti-histone antibodies
  • RF (Rheumatoid factors)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Antinuclear antibodies (ANA) in Testing for SLE

A
  • Highly sensitive (Seen in large proportion of patients).
  • But not specific (Seen in other autoimmune diseases).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SLE specific antibodies in Testing for SLE

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Complement proteins in Testing for SLE

A
  • Decrease Serum complement (C3-C4)
  • Due to its consumption.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anti-platelet antibodies & Anti-erythrocyte antibodies in Testing for SLE

A
  • Present in about 70% of patients.
  • Responsible for hemolytic anemia & thrombocytopenia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anti-histone antibodies in Testing for SLE

A
  • Present in drug induces lupus.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

RF (Rheumatoid factors) in Testing for SLE

A

+ve in 30% of patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Def of Rheumatoid Arthritis

A
  • Chronic systemic inflammatory auto immune disease that affect the joints.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Immunological testing for Rheumatoid Arthritis

A
  • Specific tests
  • Others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Specific tests for Rheumatoid Arthritis

A
  • Rheumatoid factors (RF): Positive in 75% of patients.
  • Anti-CCP autoantibodies (Anti-Cyclic Citrulinated Peptide)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Charaters of Anti-CCP autoantibodies (Anti-Cyclic Citrulinated Peptide) in testing for RA

A
  • Highly specific for RA (96%).
  • They appear before the onset of RA symptoms.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Other tests for RA

A
  • Serum complement: Decrease in presence of vasculitis.
  • Antinuclear antibodies (ANA): May be positive.
  • Hypergammaglobulinemia & Cryoglobulinemia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Def of Immunodeficiency disorders

A
  • Deficiency of one or more of the 4 major components of the immune system (B lymphocytes - T lymphocytes - phagocytic cells - complement system).
  • Which protect the individual against different viral, bacterial, fungal and protozoal infections.
15
Q

what are Primary Immunodeficiency disorders?

A
  • B cell Immunodeficiency Disorders.
  • T cell Immunodeficiency Disorders.
16
Q

Classification of Immunodeficiency disorders

A
  • Primary immunodeficiency diseases (Presented from birth)
  • Secondary immunodeficiency diseases (Acquired due to infection as AIDS).
17
Q

Examples of B-Cell Immunodeficiency disorders

18
Q

Examples of T-Cell Immunodeficiency disorders

A

DIGEORGE’S SYNDROME

(CONGENITAL THYMIC APLASIA)

19
Q

Clinical Features of T-Cell Immunodeficiency disorders

20
Laboratory assessment of immune competence
- Complement assay - Evaluation of Humoral (B cells) mediated immunity - Evaluation of Cellular (T cells) mediated immunity - Assessment of phagocytic function
21
Methods of Complement assay
- Immunoassay "Assay of C3 & C4 levels" - Functional "Hemolytic assay CH50"
22
Methods of Immunoassay "Assay of C3 & C4 levels"
* Electro immunodiffusion * Rate nephelometry * ELISA * Single radial diffusion
23
Methods for Evaluation of Humoral (B cells) mediated immunity
- Protein electrophoresis - Quantitative immunoglobulins level - IgG subclasses level - Total B cell count - Specific antibody response after immunization in vivo - Stimulation of B cells in vitro
24
Methods of Quantitative assessment of immunoglobulins level
* Radial immunodiffusion * Nephelometry * ELISA
24
Methods of assessment of IgG subclasses level
ELISA
25
Methods of assessment of Total B cell count
- Using Flow cytometry - Normally 10 - 20% of total circulating lymphocytes
26
Specific antibody response after immunization in vivo
**Principle:** Immunization with tetanus or pneumococcal polysaccharide Antigens
27
Stimulation of B cells in vitro
- By Mitogen or Antigen, and assessment of immunoglobulin release
28
Evaluation of Cellular (T cells) mediated immunity
- Total Lymphocytes count - Monoclonal antibodies to T cell subsets - Total T cell count - Delayed cutaneous hypersensitivity skin test in vivo - Lymphocyte response in vitro
29
# MOAs = Method of assessment MOAs of Total Lymphocytes count
Normally > 1200/ul "At any age"
29
MOAs of Monoclonal antibodies to T cell subsets
Using Flow cytometry
30
MOAs of Total T cell count
- Using Flow cytometry - Normally >60% of total circulating lymphocytes
31
MOAs of Delayed cutaneous hypersensitivity skin test in vivo
- Using PPD - Used to evaluate specific cellular immunity to antigen
31
MOAs of Lymphocyte response in vitro
- By Mitogen or Antigen
32
Assessment of phagocytic function
- Nitro-blue tetrazolium test - Chemiluminescence - Chemotaxis - Assessment of superoxide production - Enzyme tests - Genetic analysis
33
what is Nitro-blue tetrazolium test used in?
Used lo diagnosis of CGD
33
Chemiluminescence
Albnormal in... * CGD * Myeloperoxidase deficiency
34
MOAs of Chemotaxis
- **Principle:** Measure ability of neutrophils to move in a directed, migratory pattern toward chemotactic substance
35
when is Chemotaxis abnormal?
- Abnormal in various disorders "Not specific"
36
Superoxide production in CGD
- Absenl in CGD - Defective in other syndromes
37
Genetic analysis
Available for * CGD * LAD * Chediak Higashi syndrome
37
Indication of Enzyme tests
* e.g., G6PD - Myeloperoxidase